Z
Power Law company profile
Zymeworks
Biotech & Life Sciences · Vancouver, Canada · Founded 2003 · IPO 2017 Unicorn
Valuation
$1.86B
Market cap · Apr/2026
Revenue
$106M
Latest reported FY
Global footprint
Where Zymeworks has talent and traffic
Web traffic by country
23K
monthly visits
across markets
across markets
🇨🇦 Canada55.7%
🇺🇸 United States34.8%
🏳️ Korea6.5%
🏳️ Republic of1.7%
🇮🇳 India0.9%
Patent intelligence
$143M patent portfolio · 88 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$143M
7.7% of market cap · 2.2× smaller than top peer Exact Sciences ($319M)
88 active patent families
Where Zymeworks innovates
OncologyCancer researchAntigenBiliary tract carcinomaBiliary tract
Above peer median on Legal
Quality vs same-sector peers
Zymeworks on the five Patsnap quality dimensions
Zymeworks in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Zymeworks concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Zymeworks and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Zymeworks on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.